Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Synaptic discovers potent and selective human alpha1D-adrenoceptor antagonists

Feb. 24, 2000

Potent and selective alpha1D-adrenoceptor antagonists presented by Abbott

Feb. 18, 2000

Cortex receives notice of allowance for sexual dysfunction patent

Feb. 16, 2000

Preclinical studies support potential new indication for tamsulosin

Feb. 14, 2000

Kissei compounds display excellent beta3-adrenoceptor-stimulating effects

Feb. 11, 2000

Nastech claims formulations of sildenafil for nasal delivery

Feb. 11, 2000

Inhibitors of cGMP-PDEs under study at Bayer

Feb. 9, 2000

RenaGel receives marketing approval in the E.U.

Feb. 4, 2000

Edex/Viridal preferred, more efficacious than other ED therapies

Feb. 2, 2000

Patients prefer Invicorp over Caverject

Feb. 1, 2000

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...